轨道 发表于 2025-3-26 23:48:07
Status of Contraceptive Technology Developmentend, this article will provide information on (1) the contraceptive development effort—who is doing it, where, and with what resources; (2) the complexity of risk and benefit issues being addressed; and (3) the consumer inputs needed in the contraceptive development system.排名真古怪 发表于 2025-3-27 02:35:52
Reponsesaid. I come from south Texas, but I’ve also worked in the South. Just as I didn’t understand these terms, many of the women I work with don’t understand what these drugs are or what their effects are.Adrenal-Glands 发表于 2025-3-27 08:01:44
http://reply.papertrans.cn/19/1889/188856/188856_33.pnganarchist 发表于 2025-3-27 12:22:17
The Depo-Provera Weaponsystems. For example, in a paper he co-authored and submitted for the hearing record, one witness used such terms as “the vaginal delivery system,” “target organ,” “subject compliance,” “delivery platform,” and “the target population.”LINE 发表于 2025-3-27 15:29:23
http://reply.papertrans.cn/19/1889/188856/188856_35.png无效 发表于 2025-3-27 18:24:20
Vom binomischen Satz und seinen Anwendungen,—a clutter of biomedical technology surrounds it. Drugs, devices, and instruments besiege us—to block or ease conception; to foster or terminate gestation; to monitor or hasten birth. And recently emerging uses of technology include the design of progeny to meet specifications, as well as the creatiAntagonist 发表于 2025-3-27 21:58:11
http://reply.papertrans.cn/19/1889/188856/188856_37.png类人猿 发表于 2025-3-28 05:55:42
http://reply.papertrans.cn/19/1889/188856/188856_38.pngGROVE 发表于 2025-3-28 06:22:42
,Theorie des Größten und Kleinsten, long time has been primarily an issue of politics, and not of technology.. However, the politics of contraception changed dramatically with the shift in technological base from products developed by lay men and women (condoms, diaphragms, and pessaries) to products emerging from biomedical laborato蔑视 发表于 2025-3-28 11:35:50
https://doi.org/10.1007/978-3-642-91320-4end, this article will provide information on (1) the contraceptive development effort—who is doing it, where, and with what resources; (2) the complexity of risk and benefit issues being addressed; and (3) the consumer inputs needed in the contraceptive development system.